Genetic roadmap for metastatic breast cancer: CATCH trial aims to match patients to targeted therapies
NCT ID NCT05652569
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
The CATCH trial is a large observational study for people with metastatic breast cancer. It uses advanced genetic testing on tumor biopsies to find unique biomarkers and drug targets. The goal is to create a precision medicine platform that helps guide patients toward the most promising clinical trials and targeted treatments. This study does not test a new drug itself but aims to improve how treatments are chosen.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this platform could help match more metastatic breast cancer patients with targeted therapies and clinical trials tailored to their tumor's genetic profile.
- What could go wrong
- This is an observational diagnostic study, not a treatment trial. It may not directly improve outcomes, and genomic profiling may not always find actionable targets.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Caritas Hospital St. Josef
RECRUITINGRegensburg, Germany
-
Charité
RECRUITINGBerlin, Germany
-
Medical Faculty and University Hospital Carl Gustav Carus
RECRUITINGDresden, Germany
-
National Center for Tumor Diseases
RECRUITINGHeidelberg, Germany
-
Robert-Bosch-Krankenhaus Stuttgart
RECRUITINGStuttgart, Germany
-
University Hospital Augsburg
RECRUITINGAugsburg, Germany
-
University Hospital Erlangen
RECRUITINGErlangen, Germany
-
University Hospital Essen
RECRUITINGEssen, Germany
-
University Hospital Köln
RECRUITINGCologne, Germany
-
University Hospital Tübingen
RECRUITINGTübingen, Germany
-
University Hospital Ulm
RECRUITINGUlm, Germany
-
University Hospital Würzburg
RECRUITINGWürzburg, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug attack shrink Hard-to-Treat breast cancer?
- Can mapping tumor DNA unlock personalized breast cancer care?
- Could a personal coach at home boost energy for cancer patients?
- Can an immune booster help chemotherapy fight metastatic breast cancer?
- Can a Four-Drug cocktail tame a tough breast cancer?
- Can a new drug outsmart resistant breast cancer?